- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03105037
The Effect of Supraglottic Airway Insertion on the Accuracy of Cricothyroid Membrane Identification in Females
The Effect of Supraglottic Airway Insertion on the Accuracy of Cricothyroid Membrane Identification in Females- a Prospective Observational Study.
Prospective, observational, study that will examine if a sited supraglottic airway (the igel) will increase the accuracy of identifying the cricothyroid membrane in female patients.
Consented patients that meet inclusion criteria are assessed by clinicians under general anaesthesia with and without a supraglottic airway in situ. The accuracy of CTM identification by palpation will be evaluated using ultrasound.
Study Overview
Status
Conditions
Detailed Description
Palpation of the airway structures results in misidentification of the cricothyroid membrane (CTM) in a high proportion of women. Female front of neck anatomy is less distinct compared to males with reduced angulation of the laryngeal cartilages making it harder to distinguish the relevant landmarks. In obese patients, overlying subcutaneous tissue compounds this problem and several studies have demonstrated poor success identifying the CTM by palpation in this population. Supraglottic airway device (SAD) insertion precedes emergency front of neck access attempts in the stepwise progression from failed intubation to cricothyroidotomy. The nature and clinical implication of SAD insertion on cricothyroidotomy remain unstudied.
Sixty four patients will undergo front of neck airway assessment by volunteer clinicians with and without a SAD in situ (control and SAD assessments, within-subjects design). The patients are fasting women presenting for routine gynaecological surgery. Eight anaesthetists, at different levels of training, will perform eight individual CTM assessments with and without the SAD in situ.
Ultrasound images will be captured in the sagittal plane immediately before and after supraglottic airway insertion. Images are then downloaded, anonymised and randomised for blinded digital analysis.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Dublin, Ireland
- The Rotunda Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women attending for routine surgery
Exclusion Criteria:
- unable to give informed consent
- abnormal neck anatomy
- history of gastroesophageal reflux
- history of neck surgery or radiotherapy
- contraindication to supraglottic airway device insertion
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Study group
CTM assessed with supraglottic airway in situ and without
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
accurate identification of the cricothyroid membrane
Time Frame: At clinician assessment, on the day of patient recruitment.
|
accuracy of cricothyroid membrane identification, measured as either successful identification or unsuccessful (binary outcome).
A successful identification is within 5mm of the midline and within the upper and lower borders of the cricothyroid membrane as measured using ultrasound.
|
At clinician assessment, on the day of patient recruitment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Accurate identification of the midline of the neck
Time Frame: At clinician assessment, on the day of patient recruitment.
|
Accurate identification of the midline of the neck, binary outcome.
A successful identification is within 5mm of the midline of the cricothyroid membrane as measured using ultrasound.
|
At clinician assessment, on the day of patient recruitment.
|
Difficulty of cricothyroid membrane assessment
Time Frame: At clinician assessment, on the day of patient recruitment.
|
Difficulty of assessing the cricothyroid membrane as graded subjectively by the clinician using a visual analogue scale (VAS) where '0' is the easiest possible assessment of the location of the cricothyroid membrane and '10' is the most difficult possible assessment of the location of the cricothyroid membrane.
|
At clinician assessment, on the day of patient recruitment.
|
Time taken to attempt localisation of the cricothyroid membrane
Time Frame: At clinician assessment, on the day of patient recruitment.
|
The time taken in seconds to attempt localisation of the cricothyroid membrane
|
At clinician assessment, on the day of patient recruitment.
|
Distance from clinician assessment to actual cricothyroid membrane location
Time Frame: On blinded, retrospective ultrasound analysis of images captured at the time of clinician assessment of the cricothyroid membrane. Blinded retrospective ultrasound assessment is to take place within 3 months of patient recruitment
|
The distance measured from the clinicians estimate of where the cricothyroid membrane is to where the actual location of the CTM is using ultrasound and measured in millimetres
|
On blinded, retrospective ultrasound analysis of images captured at the time of clinician assessment of the cricothyroid membrane. Blinded retrospective ultrasound assessment is to take place within 3 months of patient recruitment
|
The distance from the skin to the first tracheal ring
Time Frame: On blinded, retrospective ultrasound analysis of images captured at the time of clinician assessment of the cricothyroid membrane. Blinded retrospective ultrasound assessment is to take place within 3 months of patient recruitment
|
The distance from the skin to the superficial surface of the first tracheal ring measured in millimetres using digital analysis of ultrasound images
|
On blinded, retrospective ultrasound analysis of images captured at the time of clinician assessment of the cricothyroid membrane. Blinded retrospective ultrasound assessment is to take place within 3 months of patient recruitment
|
The distance from the skin to the cricoid cartilage
Time Frame: On blinded, retrospective ultrasound analysis of images captured at the time of clinician assessment of the cricothyroid membrane. Blinded retrospective ultrasound assessment is to take place within 3 months of patient recruitment
|
The distance from the skin to the superficial surface of the first tracheal ring measured in millimetres using digital analysis of ultrasound images
|
On blinded, retrospective ultrasound analysis of images captured at the time of clinician assessment of the cricothyroid membrane. Blinded retrospective ultrasound assessment is to take place within 3 months of patient recruitment
|
The angle between the surface tissue interface of the cricothyroid membrane and the trachea
Time Frame: On blinded, retrospective ultrasound analysis of images captured at the time of clinician assessment of the cricothyroid membrane. Blinded retrospective ultrasound assessment is to take place within 3 months of patient recruitment
|
The angle between the surface tissue interface of the cricothyroid membrane and the trachea measured in degrees using digital analysis of ultrasound images
|
On blinded, retrospective ultrasound analysis of images captured at the time of clinician assessment of the cricothyroid membrane. Blinded retrospective ultrasound assessment is to take place within 3 months of patient recruitment
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Conan McCaul, Prof
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC-2017-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Airway Obstruction
-
Beth Israel Deaconess Medical CenterMedWaves, IncRecruitingAirway Obstruction | Central Airway ObstructionUnited States
-
McMurray Medical Group, LLCCompletedUpper Airway ObstructionUnited States
-
Massachusetts General HospitalCompletedUpper Airway ObstructionUnited States
-
Rigshospitalet, DenmarkCompletedUpper Airway ObstructionDenmark
-
Zhongda HospitalUnknownMalignant Airway ObstructionChina
-
Assistance Publique - Hôpitaux de ParisRecruitingRespiratory Distress | Upper Airway ObstructionFrance
-
ResMedCompletedRespiratory Failure | Respiratory Insufficiency | Upper Airway ObstructionUnited States
-
Massachusetts General HospitalCompletedMechanical Ventilation Complication | Upper Airway ObstructionUnited States
-
Aerin MedicalOhio State UniversityCompletedNasal ObstructionUnited States
-
University of RochesterCompletedUpper Airway ObstructionUnited States